{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T19:27:10Z","timestamp":1792524430840,"version":"4.5.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,5,6]],"date-time":"2019-05-06T00:00:00Z","timestamp":1557100800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000723","name":"Tenovus","doi-asserted-by":"crossref","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}],"id":[{"id":"10.13039\/501100000723","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100000351","name":"British Lung Foundation","doi-asserted-by":"crossref","award":["GSK\/BLF Chair of Respiratory Research"],"award-info":[{"award-number":["GSK\/BLF Chair of Respiratory Research"]}],"id":[{"id":"10.13039\/501100000351","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pulm Med"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s12890-019-0856-0","type":"journal-article","created":{"date-parts":[[2019,5,6]],"date-time":"2019-05-06T15:00:10Z","timestamp":1557154810000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Pulmonary rehabilitation after exacerbation of bronchiectasis: a pilot randomized controlled trial"],"prefix":"10.1186","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5514-7868","authenticated-orcid":false,"given":"James D.","family":"Chalmers","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan L.","family":"Crichton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gill","family":"Brady","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Finch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mike","family":"Lonergan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas C.","family":"Fardon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,5,6]]},"reference":[{"issue":"5","key":"856_CR1","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1164\/rccm.201309-1575OC","volume":"189","author":"JD Chalmers","year":"2014","unstructured":"Chalmers JD, Goeminne P, Aliberti S, et al. The bronchiectasis severity index. An international derivation and validation study. Am J Respir Crit Care Med. 2014;189(5):576\u201385. \n                    https:\/\/doi.org\/10.1164\/rccm.201309-1575OC\n                    \n                  .","journal-title":"Am J Respir Crit Care Med"},{"issue":"11","key":"856_CR2","doi-asserted-by":"publisher","first-page":"1410","DOI":"10.1164\/rccm.201711-2202OC","volume":"197","author":"JD Chalmers","year":"2018","unstructured":"Chalmers JD, Aliberti S, Filonenko A, et al. Characterization of the \u201cfrequent Exacerbator phenotype\u201d in bronchiectasis. Am J Respir Crit Care Med. 2018;197(11):1410\u201320. \n                    https:\/\/doi.org\/10.1164\/rccm.201711-2202OC\n                    \n                  .","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"856_CR3","doi-asserted-by":"publisher","first-page":"1701953","DOI":"10.1183\/13993003.01953-2017","volume":"51","author":"David Ara\u00fajo","year":"2018","unstructured":"Araujo D, Shteinberg M, Aliberti S, et al. The independent contribution of Pseudomonas aeruginosa infection to long-term clinical outcomes in bronchiectasis. Eur Respir J. 2018;51(2). \n                    https:\/\/doi.org\/10.1183\/13993003.01953-2017\n                    \n                  .","journal-title":"European Respiratory Journal"},{"issue":"5","key":"856_CR4","doi-asserted-by":"publisher","first-page":"1701127","DOI":"10.1183\/13993003.01127-2017","volume":"50","author":"Aarash D. Saleh","year":"2017","unstructured":"Saleh AD, Kwok B, Brown JS, Hurst JR. Correlates and assessment of excess cardiovascular risk in bronchiectasis. Eur Respir J. 2017;50(5). \n                    https:\/\/doi.org\/10.1183\/13993003.01127-2017\n                    \n                  .","journal-title":"European Respiratory Journal"},{"issue":"12","key":"856_CR5","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1016\/S2213-2600(16)30320-4","volume":"4","author":"MJ McDonnell","year":"2016","unstructured":"McDonnell MJ, Aliberti S, Goeminne PC, et al. Comorbidities and the risk of mortality in patients with bronchiectasis: an international multicentre cohort study. Lancet Respir Med. 2016;4(12):969\u201379. \n                    https:\/\/doi.org\/10.1016\/S2213-2600(16)30320-4\n                    \n                  .","journal-title":"Lancet Respir Med"},{"key":"856_CR6","doi-asserted-by":"publisher","DOI":"10.1186\/s12931-015-0167-9","volume":"16","author":"SE Brill","year":"2015","unstructured":"Brill SE, Patel ARC, Singh R, Mackay AJ, Brown JS, Hurst JR. Lung function, symptoms and inflammation during exacerbations of non-cystic fibrosis bronchiectasis: a prospective observational cohort study. Respir Res. 2015;16:16. \n                    https:\/\/doi.org\/10.1186\/s12931-015-0167-9\n                    \n                  .","journal-title":"Respir Res"},{"issue":"12","key":"856_CR7","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1136\/thoraxjnl-2016-208481","volume":"71","author":"MJ McDonnell","year":"2016","unstructured":"McDonnell MJ, Aliberti S, Goeminne PC, et al. Multidimensional severity assessment in bronchiectasis: an analysis of seven European cohorts. Thorax. 2016;71(12):1110\u20138. \n                    https:\/\/doi.org\/10.1136\/thoraxjnl-2016-208481\n                    \n                  .","journal-title":"Thorax."},{"issue":"5","key":"856_CR8","doi-asserted-by":"publisher","first-page":"1601532","DOI":"10.1183\/13993003.01532-2016","volume":"49","author":"Arietta Spinou","year":"2017","unstructured":"Spinou A, Siegert RJ, Guan W-J, et al. The development and validation of the bronchiectasis health questionnaire. Eur Respir J. 2017;49(5). \n                    https:\/\/doi.org\/10.1183\/13993003.01532-2016\n                    \n                  .","journal-title":"European Respiratory Journal"},{"issue":"5","key":"856_CR9","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1016\/j.rmed.2008.11.005","volume":"103","author":"AL Lee","year":"2009","unstructured":"Lee AL, Button BM, Ellis S, et al. Clinical determinants of the 6-minute walk test in bronchiectasis. Respir Med. 2009;103(5):780\u20135. \n                    https:\/\/doi.org\/10.1016\/j.rmed.2008.11.005\n                    \n                  .","journal-title":"Respir Med"},{"issue":"7","key":"856_CR10","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1164\/rccm.201203-0487OC","volume":"186","author":"JD Chalmers","year":"2012","unstructured":"Chalmers JD, Smith MP, McHugh BJ, Doherty C, Govan JR, Hill AT. Short- and long-term antibiotic treatment reduces airway and systemic inflammation in non-cystic fibrosis bronchiectasis. Am J Respir Crit Care Med. 2012;186(7):657\u201365. \n                    https:\/\/doi.org\/10.1164\/rccm.201203-0487OC\n                    \n                  .","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"856_CR11","doi-asserted-by":"publisher","first-page":"1702497","DOI":"10.1183\/13993003.02497-2017","volume":"51","author":"Miguel Angel Martinez-Garc\u00eda","year":"2018","unstructured":"Martinez-Garcia MA. Pseudomonas aeruginosa infection and exacerbations in bronchiectasis: more questions than answers. Eur Respir J. 2018;51(2). \n                    https:\/\/doi.org\/10.1183\/13993003.02497-2017\n                    \n                  .","journal-title":"European Respiratory Journal"},{"issue":"1","key":"856_CR12","doi-asserted-by":"publisher","first-page":"1702557","DOI":"10.1183\/13993003.02557-2017","volume":"52","author":"Pieter C. Goeminne","year":"2018","unstructured":"Goeminne CP, Cox B, Finch S, et al. The impact of acute air pollution fluctuations on bronchiectasis pulmonary exacerbation. A case-crossover analysis. Eur Respir J. 2018. \n                    https:\/\/doi.org\/10.1183\/13993003.02557-2017\n                    \n                  .","journal-title":"European Respiratory Journal"},{"issue":"1","key":"856_CR13","doi-asserted-by":"publisher","first-page":"1701312","DOI":"10.1183\/13993003.01312-2017","volume":"51","author":"Martijn A. Spruit","year":"2018","unstructured":"Spruit MA, Singh SJ, Rochester CL, et al. Pulmonary rehabilitation for patients with COPD during and after an exacerbation-related hospitalisation: back to the future? Eur Respir J. 2018;51(1). \n                    https:\/\/doi.org\/10.1183\/13993003.01312-2017\n                    \n                  .","journal-title":"European Respiratory Journal"},{"key":"856_CR14","doi-asserted-by":"publisher","unstructured":"Puhan MA, Gimeno-Santos E, Scharplatz M, Troosters T, Walters EH, Steurer J. Pulmonary rehabilitation following exacerbations of chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2011;(10):CD005305. \n                    https:\/\/doi.org\/10.1002\/14651858.CD005305.pub3\n                    \n                  .","DOI":"10.1002\/14651858.CD005305.pub3"},{"issue":"3","key":"856_CR15","doi-asserted-by":"publisher","first-page":"1700629","DOI":"10.1183\/13993003.00629-2017","volume":"50","author":"Eva Polverino","year":"2017","unstructured":"Polverino E, Goeminne PC, McDonnell MJ, et al. European Respiratory Society guidelines for the management of adult bronchiectasis. Eur Respir J. 2017;50(3). \n                    https:\/\/doi.org\/10.1183\/13993003.00629-2017\n                    \n                  .","journal-title":"European Respiratory Journal"},{"issue":"4","key":"856_CR16","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1016\/j.apmr.2016.05.017","volume":"98","author":"AL Lee","year":"2017","unstructured":"Lee AL, Hill CJ, McDonald CF, Holland AE. Pulmonary rehabilitation in individuals with non-cystic fibrosis bronchiectasis: a systematic review. Arch Phys Med Rehabil. 2017;98(4):774\u2013782.e1. \n                    https:\/\/doi.org\/10.1016\/j.apmr.2016.05.017\n                    \n                  .","journal-title":"Arch Phys Med Rehabil"},{"key":"856_CR17","doi-asserted-by":"publisher","first-page":"g4315","DOI":"10.1136\/bmj.g4315","volume":"349","author":"NJ Greening","year":"2014","unstructured":"Greening NJ, Williams JEA, Hussain SF, et al. An early rehabilitation intervention to enhance recovery during hospital admission for an exacerbation of chronic respiratory disease: randomised controlled trial. BMJ. 2014;349:g4315.","journal-title":"BMJ."},{"issue":"6","key":"856_CR18","doi-asserted-by":"publisher","first-page":"1700051","DOI":"10.1183\/13993003.00051-2017","volume":"49","author":"Adam T. Hill","year":"2017","unstructured":"Hill AT, Haworth CS, Aliberti S, et al. Pulmonary exacerbation in adults with bronchiectasis: a consensus definition for clinical research. Eur Respir J. 2017;49(6). \n                    https:\/\/doi.org\/10.1183\/13993003.00051-2017\n                    \n                  .","journal-title":"European Respiratory Journal"},{"issue":"1","key":"856_CR19","doi-asserted-by":"publisher","first-page":"1701926","DOI":"10.1183\/13993003.01926-2017","volume":"51","author":"Gerard Mu\u00f1oz","year":"2018","unstructured":"Munoz G, de Gracia J, Buxo M, Alvarez A, Vendrell M. Long-term benefits of airway clearance in bronchiectasis: a randomised placebo-controlled trial. Eur Respir J. 2018;51(1). \n                    https:\/\/doi.org\/10.1183\/13993003.01926-2017\n                    \n                  .","journal-title":"European Respiratory Journal"},{"issue":"1","key":"856_CR20","doi-asserted-by":"publisher","first-page":"1702232","DOI":"10.1183\/13993003.02232-2017","volume":"51","author":"Conroy Wong","year":"2018","unstructured":"Wong C, Sullivan C, Jayaram L. ELTGOL airway clearance in bronchiectasis: laying the bricks of evidence. Eur Respir J. 2018;51(1). \n                    https:\/\/doi.org\/10.1183\/13993003.02232-2017\n                    \n                  .","journal-title":"European Respiratory Journal"},{"issue":"1","key":"856_CR21","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1081\/COPD-200050527","volume":"2","author":"RA Wise","year":"2005","unstructured":"Wise RA, Brown CD. Minimal clinically important differences in the six-minute walk test and the incremental shuttle walking test. COPD. 2005;2(1):125\u20139.","journal-title":"COPD."},{"issue":"4","key":"856_CR22","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1016\/j.apmr.2010.11.023","volume":"92","author":"V Gremeaux","year":"2011","unstructured":"Gremeaux V, Troisgros O, Benaim S, et al. Determining the minimal clinically important difference for the six-minute walk test and the 200-meter fast-walk test during cardiac rehabilitation program in coronary artery disease patients after acute coronary syndrome. Arch Phys Med Rehabil. 2011;92(4):611\u20139. \n                    https:\/\/doi.org\/10.1016\/j.apmr.2010.11.023\n                    \n                  .","journal-title":"Arch Phys Med Rehabil"},{"issue":"3","key":"856_CR23","doi-asserted-by":"publisher","first-page":"1600791","DOI":"10.1183\/13993003.00791-2016","volume":"49","author":"Jadwiga A. Wedzicha","year":"2017","unstructured":"Wedzicha JAEC-C, Miravitlles M, Hurst JR, et al. Management of COPD exacerbations: a European Respiratory Society\/American Thoracic Society guideline. Eur Respir J. 2017;49(3). \n                    https:\/\/doi.org\/10.1183\/13993003.00791-2016\n                    \n                  .","journal-title":"European Respiratory Journal"},{"issue":"5","key":"856_CR24","doi-asserted-by":"publisher","first-page":"1446","DOI":"10.1183\/09031936.00119114","volume":"45","author":"JD Chalmers","year":"2015","unstructured":"Chalmers JD, Aliberti S, Blasi F. Management of bronchiectasis in adults. Eur Respir J. 2015;45(5):1446\u201362. \n                    https:\/\/doi.org\/10.1183\/09031936.00119114\n                    \n                  .","journal-title":"Eur Respir J"},{"issue":"1","key":"856_CR25","doi-asserted-by":"publisher","first-page":"1702052","DOI":"10.1183\/13993003.02052-2017","volume":"51","author":"Anthony De Soyza","year":"2018","unstructured":"De Soyza A, Aksamit T, Bandel T-J, et al. RESPIRE 1: a phase III placebo-controlled randomised trial of ciprofloxacin dry powder for inhalation in non-cystic fibrosis bronchiectasis. Eur Respir J. 2018;51(1). \n                    https:\/\/doi.org\/10.1183\/13993003.02052-2017\n                    \n                  .","journal-title":"European Respiratory Journal"},{"issue":"1","key":"856_CR26","doi-asserted-by":"publisher","first-page":"1702053","DOI":"10.1183\/13993003.02053-2017","volume":"51","author":"Timothy Aksamit","year":"2018","unstructured":"Aksamit T, De Soyza A, Bandel T-J, et al. RESPIRE 2: a phase III placebo-controlled randomised trial of ciprofloxacin dry powder for inhalation in non-cystic fibrosis bronchiectasis. Eur Respir J. 2018;51(1). \n                    https:\/\/doi.org\/10.1183\/13993003.02053-2017\n                    \n                  .","journal-title":"European Respiratory Journal"},{"issue":"1","key":"856_CR27","doi-asserted-by":"publisher","first-page":"1702444","DOI":"10.1183\/13993003.02444-2017","volume":"51","author":"Sanjay H. Chotirmall","year":"2018","unstructured":"Chotirmall SH, Chalmers JD. RESPIRE: breathing new life into bronchiectasis. Eur Respir J. 2018;51(1). \n                    https:\/\/doi.org\/10.1183\/13993003.02444-2017\n                    \n                  .","journal-title":"European Respiratory Journal"},{"issue":"1","key":"856_CR28","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1136\/thoraxjnl-2014-205918","volume":"70","author":"AL Quittner","year":"2015","unstructured":"Quittner AL, O\u2019Donnell AE, Salathe MA, et al. Quality of life questionnaire-bronchiectasis: final psychometric analyses and determination of minimal important difference scores. Thorax. 2015;70(1):12\u201320. \n                    https:\/\/doi.org\/10.1136\/thoraxjnl-2014-205918\n                    \n                  .","journal-title":"Thorax."},{"issue":"3","key":"856_CR29","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1183\/13993003.01888-2015","volume":"48","author":"S Aliberti","year":"2016","unstructured":"Aliberti S, Masefield S, Polverino E, et al. Research priorities in bronchiectasis: a consensus statement from the EMBARC clinical research collaboration. Eur Respir J. 2016;48(3):632\u201347. \n                    https:\/\/doi.org\/10.1183\/13993003.01888-2015\n                    \n                  .","journal-title":"Eur Respir J"},{"issue":"1","key":"856_CR30","doi-asserted-by":"publisher","first-page":"00081","DOI":"10.1183\/23120541.00081-2015","volume":"2","author":"James D. Chalmers","year":"2016","unstructured":"Chalmers JD, Aliberti S, Polverino E, et al. The EMBARC European bronchiectasis registry: protocol for an international observational study. ERJ open Res. 2016;2(1). \n                    https:\/\/doi.org\/10.1183\/23120541.00081-2015\n                    \n                  .","journal-title":"ERJ Open Research"}],"container-title":["BMC Pulmonary Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12890-019-0856-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12890-019-0856-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12890-019-0856-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,4]],"date-time":"2020-05-04T23:06:10Z","timestamp":1588633570000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpulmmed.biomedcentral.com\/articles\/10.1186\/s12890-019-0856-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,6]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["856"],"URL":"https:\/\/doi.org\/10.1186\/s12890-019-0856-0","relation":{},"ISSN":["1471-2466"],"issn-type":[{"value":"1471-2466","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5,6]]},"assertion":[{"value":"14 August 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 April 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 May 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was approved by the East of Scotland ethics committee and all patients gave written informed consent (13\/ES\/0062).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"85"}}